Tissue Drug Levels of HIV Medications

Completed

Conditions studied: Human Immunodeficiency Virus

In brief

The aim of this study is to find out why HIV continues to make copies in people taking HIV drugs. The investigators want to know if the medications most people use to treat HIV get into the lymphatic tissue where HIV persists.

Key facts

Study ID

NCT01490346

Run by

University of Minnesota

People needed

22

Starts

2008-09-01

Expected to finish

2014-09-01

Last updated by the study team

2015-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV+
• Treatment naive or >30 days off ARV therapy
• Documented sensitivity to prescribed antiretrovirals
• Age ≥ 18 years
• Negative pregnancy test for eligible women of childbearing potential
• Ready to start ARV therapy

You may not qualify if…

• Contraindications to surgical \& endoscopy procedures (as judged by PI)
• Psychiatric or psychological illness that would make adherence to protocol procedures unlikely
• Pregnancy

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.